CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
- 4 Open-market sale CEO sold 8,000 shares at an average $14.16 ($113,240)
- 4 Exercise or conversion CEO acquired 6,172 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,201 shares (option exercise)
- 4 Open-market sale CEO sold 10,395 shares at $9.51 ($98,856)
- 4 Open-market sale Director sold 12,806 shares at an average $9.32 ($119,336)
- 4 Derivatives Options or other derivatives
Page 9 of 19 · 370 filings